GRASS: Does Routine Assessment of Gastric Residuals in Preterm Neonates Influence Time Taken to Reach Full Enteral Feeding?

Sponsor
Institute for the Care of Mother and Child, Prague, Czech Republic (Other)
Overall Status
Unknown status
CT.gov ID
NCT03111329
Collaborator
Coombe Women and Infants University Hospital (Other)
50
2
2
26.8
25
0.9

Study Details

Study Description

Brief Summary

The study aims to compare routine assessment of gastric residuals versus no assessment of residuals in preterm neonates with respect to time taken for achieving full enteral feeding and the incidence of possible complications, such as feeding intolerance, necrotizing enterocolitis, sepsis etc.

Condition or Disease Intervention/Treatment Phase
  • Other: No aspiration of gastric residuals
N/A

Detailed Description

In general, regular assessment of gastric residuals and itsĀ“ evaluation prior to every feeding is considered standard practice for preterm neonates in neonatal intensive care units. It is believed useful to confirm correct placement of the orogastric or nasogastric tube and thought of as necessary to aid the decision of enteral feeding advancement by informing about possible remains of contents from previous feeding. Furthermore, evaluation of gastric residuals is routinely performed in order to assess for feeding intolerance and used as a possible indicator of risk for development of necrotizing enterocolitis.

However there is conflicting evidence to support the approach of routine gastric residuals assessment and it seems unclear whether it confers any clinical benefit. Withholding of enteral feeding or cessation of advancement in the amounts given due to misinterpretation of routine gastric aspirates may have a negative impact on the preterm neonate. This can potentially involve prolonged indwelling of venous catheters, higher risk of infection and growth restriction with potentially worse developmental outcome in particular for very low birth weight infants.

This randomized controlled clinical study aims to compare a control group with regular assessment and evaluation of gastric residuals and an intervention group with no routine assessment of residuals prior to feeding advancement, for the time taken to reach full enteral feeding and for occurrence of any observed complications including necrotizing enterocolitis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomization into 2 groups (interventional and control) with crossover rescue strategy.Randomization into 2 groups (interventional and control) with crossover rescue strategy.
Masking:
Single (Outcomes Assessor)
Masking Description:
Open label during intervention, assessor of outcomes will be blinded to group allocations
Primary Purpose:
Supportive Care
Official Title:
A Prospective, Randomized and Controlled Trial Comparing the Role of no Gastric Residual ASSessment and Standard Gastric Residual Measurement for the Achievement of Full Enteral Feeding in Preterm Infants
Actual Study Start Date :
Oct 6, 2017
Anticipated Primary Completion Date :
Dec 30, 2019
Anticipated Study Completion Date :
Dec 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: GRASS - Intervention group

The intervention group (GRASS) will receive 3 hourly feeds, with no gastric residuals being aspirated. Solely opening of the nasogastric tube once every 6 hours to relieve possible backflow of gastric content will be allowed. Amount of enteral feeds given and increase in dose will be specified in an enteral feeding plan prior to start of the study. Amount of enteral feeds given will increase every six hours with a calculated overall increase of 20 ml/kg of birth weight in the total amount given every 24 hours. Intervention = NO aspiration of gastric residuals

Other: No aspiration of gastric residuals
No assessment of gastric residuals will be performed prior to administering 3-hourly feeds with increasing amounts of the feeds given as per a predefined plan

No Intervention: Standard Approach group

Standard Approach group serving as control group will be treated as per standard approach - participants will be fed 3 hourly and gastric residuals checked via nasogastric tube prior to each feed. Amount of enteral feeds given and increase in dose will be specified in an enteral feeding plan prior to start of the study. Amount of enteral feeds given will increase every six hours with a calculated overall increase of 20 ml/kg of birth weight in the total amount given every 24 hours.

Outcome Measures

Primary Outcome Measures

  1. Number of days taken to achieve full enteral feeding (i.e. dose of 100ml/kg/day) [5 days after delivery for yes or no answer to whether full enteral feeding has been achieved, thereafter daily for the first three weeks until full enteral feeding has been reached]

    Time taken (in hours) to reach full enteral feeding, defined as overall dose of 100ml of feeds/kg of birth weight/ day

Secondary Outcome Measures

  1. Withholding of enteral feeding [Through first (on average) two to three weeks of the study until full enteral feeding is achieved.]

    The need to withhold enteral feeds due to clinical situation as per clinical judgement of the clinician in charge

  2. Total duration of parenteral infusion [Through first (on average) two to three weeks of the study until full enteral feeding is achieved.]

    The length of time (in hours) that parenteral infusion is needed

  3. Total duration of indwelling central venous catheter [Through first (on average) two to three weeks of the study until full enteral feeding is achieved.]

    The length of time (in hours) that an indwelling central venous catheter is needed

  4. Hypoglycaemia [Through first (on average) two to three weeks of the study until full enteral feeding is achieved.]

    Any episodes of hypoglycaemia (value less than 2,5 mmol/l) after attainment of full enteral feeding

  5. Late onset sepsis [Duration of hospitalization, an average of 8-15 weeks]

    The incidence of late onset sepsis

  6. Necrotizing enterocolitis [Duration of hospitalization, an average of 8-15 weeks]

    The incidence of necrotizing enterocolitis

  7. Spontaneous intestinal perforation [Duration of hospitalization, an average of 8-15 weeks]

    The incidence of spontaneous intestinal perforation

  8. Bronchopulmonary dysplasia [At timepoint of reached 36 gestational weeks of the neonate]

    Incidence of bronchopulmonary dysplasia

  9. Intraventricular and periventricular haemorrhage [Duration of hospitalization, an average of 8-15 weeks]

    The incidence of intraventricular and periventricular haemorrhage (stage I-IV)

  10. Retinopathy of prematurity [Duration of hospitalization, an average of 8-15 weeks]

    Incidence of retinopathy of prematurity (stage I-V)

  11. Neurodevelopment [Follow up at 24 months of corrected age of the child]

    Assessment of neurodevelopmental outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
26 Weeks to 30 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Preterm neonate, born between 26+0 and 30+0 weeks of gestation

  • Birth weight below 1500g

  • Parental informed consent obtained

Exclusion Criteria:
  • Intrauterine growth retardation (birth weight below 5th centile for given gestational age and gender)

  • Life-threatening events requiring full resuscitation at the delivery room (severe hypoxia, bleeding), and persistently raised lactate value of more than 5 mmol/l

  • Circulatory instability requiring treatment with inotropes

  • Highly suspected early onset sepsis with alteration of general clinical state, in particular with worsened peripheral perfusion and circulatory decompensation prior to study begin (during the first 6 hours after admission to NICU)

  • Known malformations of gastrointestinal tract, known diagnosis of congenital diaphragmatic hernia, any other life-limiting serious congenital malformations

Contacts and Locations

Locations

Site City State Country Postal Code
1 Institute for the Care of Mother and Child Prague Czechia
2 Coombe Women and Infants University Hospital Dublin Ireland

Sponsors and Collaborators

  • Institute for the Care of Mother and Child, Prague, Czech Republic
  • Coombe Women and Infants University Hospital

Investigators

  • Study Chair: Zbynek Stranak, MD, Institute for the Care of Mother and Child in Prague

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Institute for the Care of Mother and Child, Prague, Czech Republic
ClinicalTrials.gov Identifier:
NCT03111329
Other Study ID Numbers:
  • GRASS-1
First Posted:
Apr 12, 2017
Last Update Posted:
Nov 20, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Institute for the Care of Mother and Child, Prague, Czech Republic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 20, 2018